Innovaccer

Healthcare data and AI platform that unifies patient data and offers copilots and analytics for providers, payers and life sciences.

View on the globe

$179MEquity raised in 2025–20262025 $179M · 2026 — · 1 equity round
$179MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed
$96MSecondary salesnot counted as equity · all in 2025–2026

Rounds over time log-scaled amounts

Funding history: 2 rounds from 9 Jan 2025 to 9 Jan 2025, $179M equity disclosed, plus $96M debt or secondary. Earlier rounds exist but are not sourced.9 Jan 2025: Series F (primary portion), $179M; 9 Jan 2025: Secondary sale alongside Series F (secondary, not equity), $96M$1M$3M$10M$30M$100M$300MEarlier rounds exist but are not sourced yet← earlier rounds not sourcedest. 2014Q3Q42025Q2Q3Q4Equity roundDebt / secondary9 Jan 2025 · Series F (primary portion) · $179M9 Jan 2025 · Secondary sale alongside Series F (secondary, not counted as equity) · $96MSeries F · $179MSecondary · $96M
Funding history: 2 rounds from 9 Jan 2025 to 9 Jan 2025, $179M equity disclosed, plus $96M debt or secondary. Earlier rounds exist but are not sourced.9 Jan 2025: Series F (primary portion), $179M; 9 Jan 2025: Secondary sale alongside Series F (secondary, not equity), $96M$1M$3M$10M$30M$100M$300MEarlier rounds exist but are not sourced yetearlier rounds not sourced’14Q3Q42025Q2Q3Q4Equity roundDebt / secondary9 Jan 2025 · Series F (primary portion) · $179M9 Jan 2025 · Secondary sale alongside Series F (secondary, not counted as equity) · $96M$179M$96M sec.

Funding history 2 rounds · 3 sources · newest first

Earlier rounds not yet sourced. Innovaccer was founded in 2014 and raised before 9 Jan 2025; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Secondary sale alongside Series FSecondary sale · not equity
    Amount$96M
    Post-money—
    ◔ Reported
    Note
    About 35% of the announced $275M (approximately $96M, derived) provided liquidity to seed and Series A investors per TechCrunch; Crunchbase News confirms only that the round mixed primary and secondary. Buyers not itemized.
    Sources
  2. Series F (primary portion)
    Amount$179M
    Post-money—
    ✓ Confirmed
    Also
    B Capital, Kaiser Permanente, Banner Health, Microsoft, Danaher Ventures, Generation Investment Management
    Note
    Announced as $275M; TechCrunch reports about 35% was secondary liquidity for seed and Series A investors, so the primary portion is about $179M (derived; secondary recorded separately). TechCrunch cites a source putting the primary post-money valuation at about $3.45B (unconfirmed, not recorded). No lead named. Earlier rounds (incl. a $150M round in late 2021) are not sourced here.
    Sources
  3. Earlier rounds not yet sourced

Investors 6

  • B Capital
  • Banner Health
  • Danaher Ventures
  • Generation Investment Management
  • Kaiser Permanente
  • Microsoft

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the San Francisco hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Innovaccer and its logo are trademarks of their owners, used here for identification only.